Featured Press Releases

Lubrizol reveals a significant milestone for its innovative, patented Apisolex™ polymer excipient

Lubrizol reveals a significant milestone for its innovative, patented Apisolex™ polymer excipient

China approves the Corina Intrauterine Drug-Eluting System as a novel treatment for moderate-to-severe intrauterine adhesions (IUA)

China approves the Corina Intrauterine Drug-Eluting System as a novel treatment for moderate-to-severe intrauterine adhesions (IUA)

  • 23 Aug 2024

Corina Intrauterine Drug-Eluting System ("Corina"), developed by Yipurun (Shanghai) Biotechnology...

Hanmi Pharmaceutical and Beijing Hanmi advance clinical trials for BH3120, their co-developed next-generation cancer immunotherapy

Hanmi Pharmaceutical and Beijing Hanmi advance clinical trials for BH3120, their co-developed next-generation cancer immunotherapy

Zydus announces an exclusive licensing and supply agreement for two Gadolinium-based MRI injectable contrast agents in the U.S

Zydus announces an exclusive licensing and supply agreement for two Gadolinium-based MRI injectable contrast agents in the U.S

IKA introduces new accessories for the HABITAT research bioreactor.

IKA introduces new accessories for the HABITAT research bioreactor.

Within one year of its launch, L&C Bio

Within one year of its launch, L&C Bio's 'Re2O' has emerged as a leading procedure in K-Medical Tourism

ProductLife Group Appoints Dr. James Burt as CEO

ProductLife Group Appoints Dr. James Burt as CEO

  • ProductLife Group
  • 24 Mar 2026
Constance Sabbagh Appointed as General Manager as Avanzanite Expands French Operations

Constance Sabbagh Appointed as General Manager as Avanzanite Expands French Operations

  • Avanzanite Bioscience B.V.
  • 24 Mar 2026
Emerging From Stealth, Oryon Cell Therapies Targets Autologous Neuron Replacement for Parkinson’s Disease and Neurodegenerative Disorders

Emerging From Stealth, Oryon Cell Therapies Targets Autologous Neuron Replacement for Parkinson’s Disease and Neurodegenerative Disorders

  • Oryon Cell Therapies
  • 23 Mar 2026
Samsung Biologics Labor Union Warns of

Samsung Biologics Labor Union Warns of "Structural Supply Chain Risk" Amid Labor Dispute, Citing Systemic Governance Failures

  • Samsung Biologics Labor Union
  • 23 Mar 2026
Convergent Therapeutics Appoints Michael Rossi to Board

Convergent Therapeutics Appoints Michael Rossi to Board

  • Convergent Therapeutics Inc.
  • 20 Mar 2026
Johnson & Johnson Announces U.S. Food and Drug Administration Approval of TECVAYLI + DARZALEX FASPRO for Relapsed/Refractory Multiple Myeloma.

Johnson & Johnson Announces U.S. Food and Drug Administration Approval of TECVAYLI + DARZALEX FASPRO for Relapsed/Refractory Multiple Myeloma.

  • Johnson & Johnson
  • 06 Mar 2026
World Drug Delivery Summit 2025
The Digital Pharma Advances Conference 2026

Most Popular
April   2026
M T W T F S S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.